Paper Details
- Home
- Paper Details
Colitis induced by sodium polystyrene sulfonate in sorbitol: A report of six cases.
Author: DhusUbal, JacobSheba S K, ParameswaranAshok, ParameswaranSarojini Ashok
Original Abstract of the Article :
Drug-related injury has been noted in virtually all organ systems, and recognition of the patterns of injury associated with medication enables modification of treatment and reduces the morbidity associated with the side effects of drugs. With the large number of new drugs being developed, documenta...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://doi.org/10.1007/s12664-016-0635-2
データ提供:米国国立医学図書館(NLM)
Colitis Induced by Sodium Polystyrene Sulfonate
This study investigates the occurrence of colitis, an inflammation of the colon, as an adverse effect of sodium polystyrene sulfonate (SPS), a medication used to treat hyperkalemia (high potassium levels in the blood). The researchers report a series of six cases where SPS administration was associated with colitis. They highlight the importance of recognizing this potential side effect, particularly in patients with uremia (excess urea in the blood) and hyperkalemia.SPS-Associated Colitis: A Potential Side Effect
The study highlights the potential for sodium polystyrene sulfonate (SPS) to cause colitis, an inflammation of the colon. The researchers report a series of cases where SPS administration was associated with colitis, emphasizing the importance of recognizing this potential side effect, particularly in patients with uremia and hyperkalemia. This information is critical for healthcare providers to consider when prescribing SPS.Managing Potassium Levels with Caution
Imagine a camel traversing a harsh desert landscape, encountering challenging terrain and potential hazards. Just as the camel needs to navigate these obstacles carefully, healthcare providers must carefully manage potassium levels in patients, considering the potential side effects of medications like SPS. This study underscores the importance of vigilant monitoring and the need to weigh the benefits and risks of SPS treatment.Dr.Camel's Conclusion
This study highlights the potential for sodium polystyrene sulfonate (SPS) to cause colitis, an inflammation of the colon. The researchers report a series of cases where SPS administration was associated with colitis, emphasizing the importance of recognizing this potential side effect, particularly in patients with uremia and hyperkalemia. Healthcare providers should carefully consider the risks and benefits of SPS treatment and monitor patients closely for signs of colitis.Date :
- Date Completed 2017-03-09
- Date Revised 2022-04-08
Further Info :
Related Literature
Article Analysis
SNS
PICO Info
in preparation
Languages
English
Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.